Cited by

• Novel mutations involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to βIII-tubulin in breast cancer.

  Wang W, Zhang H, Wang X, Patterson J, Winter P, Graham K, Ghosh S, Lee JC, Katsetos CD, Mackey JR, Tuszynski JA, Wong GK, Ludueña RF. Wang W, et al. Protoplasma. 2017 May;254(3):1163-1173. doi: 10.1007/s00709-016-1060-1. Epub 2016 Dec 9. Protoplasma. 2017. PMID: 27943021
• Precipitation of proteins by vinblastine and calcium ions.

  Wilson L, Bryan J, Ruby A, Mazia D. Wilson L, et al. Proc Natl Acad Sci U S A. 1970 Jul;66(3):807-14. doi: 10.1073/pnas.66.3.807. Proc Natl Acad Sci U S A. 1970. PMID: 5269244 Free PMC article.
• Imidazoles as potential anticancer agents.

  Ali I, Lone MN, Aboul-Enein HY. Ali I, et al. Medchemcomm. 2017 Apr 13;8(9):1742-1773. doi: 10.1039/c7md00067g. eCollection 2017 Sep 1. Medchemcomm. 2017. PMID: 30108886 Free PMC article. Review.
• Receptor mobility and receptor-cytoplasmic interactions in lymphocytes.

  Edelman GM, Yahara I, Wang JL. Edelman GM, et al. Proc Natl Acad Sci U S A. 1973 May;70(5):1442-6. doi: 10.1073/pnas.70.5.1442. Proc Natl Acad Sci U S A. 1973. PMID: 4514314 Free PMC article.
• Effect of CH-35, a novel anti-tumor colchicine analogue, on breast cancer cells overexpressing the βIII isotype of tubulin.

  Yeh LC, Banerjee A, Prasad V, Tuszynski JA, Weis AL, Bakos T, Yeh IT, Ludueña RF, Lee JC. Yeh LC, et al. Invest New Drugs. 2016 Feb;34(1):129-37. doi: 10.1007/s10637-015-0315-6. Epub 2015 Dec 21. Invest New Drugs. 2016. PMID: 26686345